We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$21.1B
AUM Growth
+$828M
(+4.1%)
Cap. Flow
-$358M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
10.93%
Holding
2,666
New
960
Increased
418
Reduced
406
Closed
754
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$244M |
| 2 |
PFPT
Proofpoint, Inc.
PFPT
|
+$160M |
| 3 |
Fortive
FTV
|
+$157M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$131M |
| 5 |
Truist Financial
TFC
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$169M |
| 2 |
Morgan Stanley
MS
|
+$151M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$143M |
| 4 |
RP
RealPage, Inc.
RP
|
+$138M |
| 5 |
McDonald's
MCD
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.15% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 11.2% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Industrials | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
CALL
Elevance Health
ELV
$84.8B
| $764K | ﹤0.01% |
+2,000
| New | +$764K |
|
1402
CALL
Zoetis
ZTS
$31B
| $764K | ﹤0.01% |
+4,100
| New | +$712K |
|
1403
Moelis & Co
MC
$4.94B
| $763K | ﹤0.01% |
+13,412
| New | +$729K |
|
|
MANT
1404
DELISTED
Mantech International Corp
MANT
| $763K | ﹤0.01% |
+8,820
| New | +$763K |
|
1405
CALL
Bristol-Myers Squibb
BMY
$130B
| $762K | ﹤0.01% |
11,400
-38,600
| -77% | -$2.52M |
|
|
ENIA
1406
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $762K | ﹤0.01% |
105,498
-951,196
| -90% | -$6.99M |
|
1407
CALL
Boston Scientific
BSX
$74.2B
| $761K | ﹤0.01% |
+17,800
| New | +$749K |
|
1408
Royal Bank of Canada
RY
$293B
| $761K | ﹤0.01% |
7,515
+2,342
| +45% | +$232K |
|
1409
VanEck Gold Miners ETF
GDX
$27.3B
| $758K | ﹤0.01% |
+22,296
| New | +$814K |
|
1410
CALL
Illumina
ILMN
$29B
| $757K | ﹤0.01% |
+1,645
| New | +$663K |
|
1411
CALL
Thermo Fisher Scientific
TMO
$223B
| $757K | ﹤0.01% |
+1,500
| New | +$708K |
|
1412
CALL
Edwards Lifesciences
EW
$53.9B
| $756K | ﹤0.01% |
+7,300
| New | +$688K |
|
1413
CALL
AbbVie
ABBV
$441B
| $755K | ﹤0.01% |
+6,700
| New | +$755K |
|
1414
MGP Ingredients
MGPI
$387M
| $755K | ﹤0.01% |
11,165
-4,210
| -27% | -$276K |
|
1415
CALL
Humana
HUM
$45B
| $753K | ﹤0.01% |
+1,700
| New | +$743K |
|
1416
Stride
LRN
$3.26B
| $753K | ﹤0.01% |
23,435
+12,674
| +118% | +$378K |
|
1417
CALL
Stryker
SYK
$134B
| $753K | ﹤0.01% |
+2,900
| New | +$742K |
|
|
CPARU
1418
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
| $753K | ﹤0.01% |
+75,000
| New | +$754K |
|
1419
Advanced Drainage Systems
WMS
$10.8B
| $751K | ﹤0.01% |
6,444
-39,470
| -86% | -$4.38M |
|
1420
CALL
AutoZone
AZO
$49.8B
| $746K | ﹤0.01% |
+500
| New | +$725K |
|
|
AUY
1421
DELISTED
Yamana Gold, Inc.
AUY
| $746K | ﹤0.01% |
176,673
-622,944
| -78% | -$3.02M |
|
1422
Chesapeake Utilities
CPK
$3.22B
| $743K | ﹤0.01% |
6,178
+3,950
| +177% | +$468K |
|
1423
CALL
CVS Health
CVS
$120B
| $743K | ﹤0.01% |
+8,900
| New | +$729K |
|
1424
Teck Resources
TECK
$32.5B
| $742K | ﹤0.01% |
32,190
+17,499
| +119% | +$398K |
|
|
WIRE
1425
DELISTED
Encore Wire Corp
WIRE
| $738K | ﹤0.01% |
9,743
+1,709
| +21% | +$132K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Balyasny Asset Management held 2,666 positions worth $21.1B, up 4.1% from $20.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management's Q2 2021 filing shows 960 new, 418 increased, 406 reduced and 754 closed positions. Its largest new stake was Nuance Communications, Inc.: 4,636,095 shares worth $252M. The largest sale was Bank of America, an estimated $169M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- Balyasny Asset Management's largest Q2 2021 buy was Nuance Communications, Inc.: 4,636,095 shares worth $252M.
- Balyasny Asset Management added most to QTS REALTY TRUST, INC. in Q2 2021, an estimated $91.6M increase.
- Balyasny Asset Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $151M.
- Balyasny Asset Management fully exited Bank of America in Q2 2021, selling an estimated $169M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $21.1B portfolio in Q2 2021.
- Balyasny Asset Management opened 960 new positions and closed 754 in Q2 2021.
- Balyasny Asset Management's portfolio value rose 4.1% quarter-over-quarter to $21.1B.
Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.